GNH USA

Europe — EMA

Olmesartán / Hidroclorotiazida Cinfa (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartán / Hidroclorotiazida Cinfa, is an Angiotensin II receptor blocker (ARB) presented as a oral tablet for systemic use.

Request sourcing

1
Pack/s

What is Olmesartan Medoxomil, Hydrochlorothiazide?

Olmesartan medoxil, the active ingredient in Olmesartán / Hidroclorotiazida Cinfa, is an Angiotensin II receptor blocker (ARB) presented as a oral tablet for systemic use. It treats hypertension, often in combination with a diuretic, and is intended for adult patients. GNH USA supplies Olmesartán / Hidroclorotiazida Cinfa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartán / Hidroclorotiazida Cinfa as a licensed, GDP‑compliant international pharmaceutical ...

What is Olmesartan Medoxomil, Hydrochlorothiazide used for?

Olmesartan medoxil combined with hydro­hydrochlorothiazide  …  ...

What are the side effects of Olmesartan Medoxomil, Hydrochlorothiazide?

Common ...

What precautions apply to Olmesartan Medoxomil, Hydrochlorothiazide?

{"error":"Invalid JSON JSON ?  "}

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Olmesartan Medoxomil, Hydrochlorothiazide
Route
Oral Use
Manufacturer
Laboratorios Cinfa S.A.
Origin
EU

Related products